For millions of people, osteoarthritis slowly breaks down the joints, bringing pain, swelling and stiffness that make free ...

An estimated 595 million people globally are living with osteoarthritis. This makes it one of the leading causes of pain and disability. Osteoarthritis is a degenerative joint disease, in which ...

A woman from Blaenau Gwent living with osteoarthritis is training to run her first marathon despite chronic joint pain.

Osteoarthritis (OA) stands as the most common joint disease in the United States, with higher prevalence rates observed in African American communities. This progressive disorder causes the gradual ...

Reviews and recommendations are unbiased and products are independently selected. Postmedia may earn an affiliate commission from purchases made through links on this page. A new study published in ...

Add Yahoo as a preferred source to see more of our stories on Google. Trish Barbato used to be highly active, playing golf, hiking, biking and anything else she could do to be outside. But arthritis ...

For millions of people living with knee osteoarthritis, treatment has long meant a choice between managing symptoms and ...

Lacosamide, an FDA-approved epilepsy drug, shows promise in reducing joint pain and reversing cartilage damage in osteoarthritis when delivered directly into the joint.

The research is still in the early stages, but phase one has proved successful, and scientists are moving on to phase 2. Learn how this could impact patients with osteoarthritis in the future. The 33 ...

Can obesity pharmacotherapy modify osteoarthritis? A new review has weighed the pain relief against the structural evidence.

In July, 2026, the British Society for Rheumatology (BSR) released their first ever recommendations for pain management in people with inflammatory arthritis, with personalised care taking centre ...